First Wave BioPharma Inc
NASDAQ:ENTO
First Wave BioPharma Inc
NASDAQ:ENTO
Price:
2.85
USD
-5.32%
Market Closed
Market Cap:
$9.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
First Wave BioPharma Inc
NASDAQ:ENTO
|
US |
|
Lechwerke AG
F:LEC
|
DE |
|
Heidelberger Beteiligungsholding AG
F:IPOK
|
DE |
|
Ipsen SA
OTC:IPSEY
|
FR |
|
Aeffe SpA
MIL:AEF
|
IT |
|
abrdn Property Income Trust Ltd
LSE:API
|
GG |
|
Delta Djakarta Tbk PT
IDX:DLTA
|
ID |
|
A
|
AutoStore Holdings Ltd
F:1IG
|
NO |
|
Polski Koncern Naftowy Orlen SA
LSE:0FMN
|
PL |
|
A
|
Athanase Innovation AB
STO:ATIN
|
SE |
|
V
|
Verses AI Inc
NEO:VERS
|
CA |
|
I
|
IMCD NV
F:INX
|
NL |
|
D
|
DOD Biotech PCL
SET:DOD
|
TH |
|
D
|
Domiki Kritis SA
F:F9P
|
GR |
|
M
|
MyMD Pharmaceuticals Inc
NASDAQ:MYMD
|
US |
|
DC Two Ltd
ASX:DC2
|
AU |
|
E
|
Entourage Health Corp
XTSX:ENTG
|
CA |
|
F
|
Flow Beverage Corp
OTC:FLWBF
|
CA |
|
Goldlion Holdings Ltd
HKEX:533
|
HK |
|
E
|
Eneraqua Technologies PLC
LSE:ETP
|
UK |
|
Spenda Ltd
ASX:SPX
|
AU |
|
Marston's PLC
LSE:MARS
|
UK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of ENTO.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ENTO
Multiples-Based Value
Base Case
Not Available
